You make some valid points.
If AVE interim results look good in December then BP would start their own trials using TPM alternatives and it would be a race to the FDA finish line.
Who would bother betting on AVE if BP is barely six months behind?
Ann: March 2024 Quarterly Activities Report & Appendix 4C, page-40
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.923M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 35 | 43869108 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 44263580 | 22 |
View Market Depth
| Last trade - 12.55pm 04/10/2024 (20 minute delay) ? |
| AVE (ASX) Chart |
Day chart unavailable